Oramed Pharmaceuticals (ORMP) EBITDA Margin (QoQ) (2016 - 2023)
Oramed Pharmaceuticals (ORMP) EBITDA Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 21,952.00 |
| Mar 31, 2023 | 58,151.00 |
| Dec 31, 2022 | -16,276.00 |
| Sep 30, 2022 | 49,318.00 |
| Jun 30, 2022 | -443.00 |
| Nov 30, 2019 | -1,604.00 |
| Aug 31, 2019 | 25,360.00 |
| May 31, 2019 | -6,221.00 |
| Feb 28, 2019 | 15,269.00 |
| Nov 30, 2018 | -17,789.00 |
| Aug 31, 2018 | 22,431.00 |
| May 31, 2018 | -21,978.00 |
| Feb 28, 2018 | -6,793.00 |
| Nov 30, 2017 | 1,451.00 |
| Aug 31, 2017 | -11,238.00 |
| May 31, 2017 | 20,147.00 |
| Feb 28, 2017 | -15,762.00 |
| Nov 30, 2016 | 427,572.00 |
| Aug 31, 2016 | -596,332.00 |
| May 31, 2016 | 282,408.00 |